The Durk Pearson & Sandy Shaw®
Life Extension NewsTM
Volume 9 No.
1 • January 2006
Health Freedom Protection Act, H.R. 4282, Introduced in Congress
Another approach to increasing access to truthful information is via legislation. This new bill (cosponsored by ten Representatives, last we heard) would, if enacted, amend the Food Drug and Cosmetic Act (FDCA) to permit truthful disease-treatment claims for foods and dietary supplements. It would prohibit the FDA and FTC from preventing anyone who sells foods or supplements from sending consumers government reports (and accurate quotes from them) and scientific papers on nutrient-disease associations. Other provisions, such as one prohibiting the FDA from waiving conflicts of interest in its food advisory panels, would help ensure more objective FDA decisions.
The proposed bill would also amend the deceptive advertising provisions of the Federal Trade Commission Act to make all publications exempt from regulation by the amendment to the FDCA to be also exempt from regulation by the FTC.
You can get a copy of the bill by phoning Emord & Associates at 202-466-6937 or by going to stopfdacensorship.org, where you can sign up as a supporter and send e-mails of support to your Congresscritters.
We have joined a long list of companies and individuals called The Coalition to End FDA and FTC Censorship, which is promoting the bill with a national grassroots campaign to educate the public and get signatures on the petition to support H.R. 4282. For your information, the following dietary supplement companies are not members of the coalition and are opposing the bill: A. M. Todd Botanical Therapeutics, Cornerstone Research & Development, Nature’s Way Products, Nelson Laboratories, One World Nutrition, Pharmanex (Division of NuSkin Enterprises), Sabinsa Corporation, Synergy Company, Tahitian Noni International, and USANA Health Services.
The bill, while a potential winner that would (if enacted) make the above lawsuit unnecessary, is far from certain to pass the House, let alone the Senate. That is why the lawsuit is continuing. A ruling in our favor in the suit may in fact help get the bill passed.